Endone IR Tablets 5 mg – Oxycodone Hydrochloride

Active Ingredient: Oxycodone Hydrochloride 5 mg

Formulation: Immediate-Release, film-coated oral tablet

Endone IR 5 mg provides rapid relief of moderate-to-severe acute pain when standard non-opioid therapies prove insufficient. Each tablet contains oxycodone, a μ-opioid receptor agonist that delivers potent analgesia with a rapid onset of action.

• Strength: 5 mg oxycodone hydrochloride per tablet
• Indication: Short-term management of severe pain requiring opioid treatment
• Onset: Fast absorption; peak plasma concentration within 1 hour (approx.)
• Dosing: Individualised – typically 5–15 mg every 4–6 hours as needed; do not exceed prescribed total daily dose
• Schedule: Schedule 8 (Controlled Drug) – Prescription Only Medicine
• Pack Size: 20 tablets per blister pack
• Excipients: Includes lactose monohydrate, microcrystalline cellulose, pre-gelatinised maize starch, colloidal anhydrous silica, and magnesium stearate (refer to full PI/CMI for complete list)
• Storage: Store below 25 °C in a cool, dry place; keep out of reach of children
• Manufacturer: Alphapharm Pty Ltd (a Viatris Company), Australia

Clinical Considerations: Reserve Endone for cases where weaker analgesics are inadequate. Monitor closely for respiratory depression, sedation, and signs of misuse or dependence. Contra-indicated in severe respiratory compromise, acute asthma, and paralytic ileus.

Prescription Only Medicine – dispensing restricted to authorised prescribers.
This information is intended for healthcare professionals. Consult the approved Product Information and Consumer Medicine Information before prescribing or dispensing.

Order Endone IR 5 mg at Medshop – your reliable partner for Schedule 8 pharmaceutical supply across Australia.